Treatment options for mild-to-moderate COVID-19 are becoming increasingly well established. A systematic review and network meta-analysis published in The BMJ evaluated 40 treatments across 187 ...

A new MITRE report by its infectious disease analytics team, recommends measures that U.S. leaders can take right now to limit the course of COVID-19: National, state, and local leaders can and must ...

• Attention is understandably focused on limiting the damage from the short-term effects of the coronavirus outbreak. But it’s likely that, once disruption and uncertainty fade, the rebound in global ...

The U.S. Food and Drug Administration approved 2025-26 COVID-19 vaccines for anyone age 65 and older and any person 6 months and older who has at least one underlying health condition that increases ...

Add Yahoo as a preferred source to see more of our stories on Google. Confusion has swirled this fall about who can receive a COVID booster, as federal health officials reworked general ...